Found: 151
Select item for more details and to access through your institution.
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 8, p. 856, doi. 10.1001/jamadermatol.2024.2131
- By:
- Publication type:
- Article
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1863, doi. 10.1007/s13555-024-01195-z
- By:
- Publication type:
- Article
308‐nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single‐center real‐world experience of treatment for palmoplantar pustulosis.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 7, p. 977, doi. 10.1111/1346-8138.17191
- By:
- Publication type:
- Article
Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20‐week interim analysis of a postmarketing surveillance study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 6, p. 779, doi. 10.1111/1346-8138.17255
- By:
- Publication type:
- Article
Dose escalation of biologic treatment in patients with moderate‐to‐severe psoriasis in Japan.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 5, p. 1, doi. 10.1111/exd.15067
- By:
- Publication type:
- Article
An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open‐label, phase 3 trial.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 3, p. 365, doi. 10.1111/1346-8138.17074
- By:
- Publication type:
- Article
Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 3, p. 391, doi. 10.1111/1346-8138.17097
- By:
- Publication type:
- Article
Physician-assessed effectiveness and patientreported outcomes in adult and adolescent patients with atopic dermatitis in the Asian subpopulation treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii38, doi. 10.1093/bjd/ljad498.040
- By:
- Publication type:
- Article
Baseline patient characteristics, physician-assessed effectiveness, patient-reported outcomes, and safety in adult atopic dermatitis patients in Japan treated with dupilumab: Real-world insights one year into the GLOBOSTAD multinational prospective observational study
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii39, doi. 10.1093/bjd/ljad498.041
- By:
- Publication type:
- Article
Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 2, p. 1, doi. 10.1111/exd.15022
- By:
- Publication type:
- Article
Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 2, p. 210, doi. 10.1111/1346-8138.17038
- By:
- Publication type:
- Article
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 99, doi. 10.1007/s13555-023-01064-1
- By:
- Publication type:
- Article
Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiative.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 10, p. 2913, doi. 10.1007/s00403-023-02729-9
- By:
- Publication type:
- Article
Prevalence of subclinical axial involvement in patients diagnosed with peripheral psoriatic arthritis on X‐rays: A single‐centre retrospective study.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 12, p. 2180, doi. 10.1111/exd.14920
- By:
- Publication type:
- Article
Expression of interleukin‐36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 12, p. 1608, doi. 10.1111/1346-8138.16914
- By:
- Publication type:
- Article
Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single‐centre retrospective study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 12, p. e1455, doi. 10.1111/jdv.19363
- By:
- Publication type:
- Article
Crosstalk: keratinocytes and immune cells in psoriasis.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1286344
- By:
- Publication type:
- Article
Real‐world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY).
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 11, p. 1415, doi. 10.1111/1346-8138.16926
- By:
- Publication type:
- Article
Improvement of severe alopecia areata after 9‐month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 11, p. e392, doi. 10.1111/1346-8138.16893
- By:
- Publication type:
- Article
Improvements in self‐confidence and satisfaction with self‐injection after introducing self‐injection of dupilumab in patients with atopic dermatitis.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2023, v. 6, n. 5, p. 152, doi. 10.1002/cia2.12313
- By:
- Publication type:
- Article
Immediate exacerbation of atopic dermatitis after switching from upadacitinib to dupilumab: A report of two cases.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2023, v. 6, n. 5, p. 168, doi. 10.1002/cia2.12302
- By:
- Publication type:
- Article
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 837, doi. 10.1007/s40257-023-00788-2
- By:
- Publication type:
- Article
Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 6, p. 749, doi. 10.1093/bjd/ljad035
- By:
- Publication type:
- Article
Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 261, doi. 10.1002/jvc2.113
- By:
- Publication type:
- Article
Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double‐blind, placebo‐controlled, global phase 3 trial.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 5, p. 588, doi. 10.1111/1346-8138.16740
- By:
- Publication type:
- Article
Psoriasis patient preferences for the use of biologics during the coronavirus era.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 5, p. 596, doi. 10.1111/1346-8138.16703
- By:
- Publication type:
- Article
Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 1039, doi. 10.1007/s13555-023-00909-z
- By:
- Publication type:
- Article
Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 4, p. 737, doi. 10.1111/jdv.18851
- By:
- Publication type:
- Article
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 3, p. 751, doi. 10.1007/s13555-022-00883-y
- By:
- Publication type:
- Article
Newly developed erythema and red papules in the face and neck with detection of demodex during dupilumab treatment for atopic dermatitis improved by discontinuation of dupilumab, switching to upadacitinib or treatment with oral ivermectin: A report of two cases
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 3, p. e300, doi. 10.1111/jdv.18743
- By:
- Publication type:
- Article
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 595, doi. 10.1007/s13555-022-00876-x
- By:
- Publication type:
- Article
Serum levels of angiogenesis‐related factors in patients with psoriasis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 2, p. 222, doi. 10.1111/1346-8138.16588
- By:
- Publication type:
- Article
Ixekizumab rapidly improves inflammatory markers in patients with generalized pustular psoriasis.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 5, p. 793, doi. 10.1111/bjd.21701
- By:
- Publication type:
- Article
Treatment patterns, healthcare resource utilization, and costs in patients with moderate‐to‐severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 11, p. 1106, doi. 10.1111/1346-8138.16543
- By:
- Publication type:
- Article
Work productivity in real‐life employed patients with plaque psoriasis: Results from the ProLOGUE study.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 10, p. 970, doi. 10.1111/1346-8138.16517
- By:
- Publication type:
- Article
Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.941071
- By:
- Publication type:
- Article
Impact of the COVID‐19 pandemic on biologic treatment in psoriasis patients: A single‐center retrospective study in Japan.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 6, p. 624, doi. 10.1111/1346-8138.16362
- By:
- Publication type:
- Article
Usefulness of Noninvasive Management With the Gutter Method for Epidermal Growth Factor Receptor Inhibitor-Induced Paronychia, Pyogenic Granuloma-Like Lesion, and Ingrown Nail.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effectiveness of tacrolimus ointment on facial lesions refractory to topical corticosteroid in patients with atopic dermatitis receiving dupilumab.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2022, v. 5, n. 1, p. 17, doi. 10.1002/cia2.12201
- By:
- Publication type:
- Article
Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 121, doi. 10.1007/s13555-021-00645-2
- By:
- Publication type:
- Article
Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 11, p. 1665, doi. 10.1111/1346-8138.16072
- By:
- Publication type:
- Article
Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2021, v. 4, n. 5, p. 145, doi. 10.1002/cia2.12178
- By:
- Publication type:
- Article
Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 9, p. e472, doi. 10.1111/1346-8138.16024
- By:
- Publication type:
- Article
Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 3, p. 943, doi. 10.1007/s13555-021-00520-0
- By:
- Publication type:
- Article
Long‐term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5‐year extension of a phase 3 study (reSURFACE 1).
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 6, p. 844, doi. 10.1111/1346-8138.15763
- By:
- Publication type:
- Article
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64‐week phase 3 study (reSURFACE 1).
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 6, p. 853, doi. 10.1111/1346-8138.15789
- By:
- Publication type:
- Article
Edoxaban prevented adverse effects including pyrexia and elevation of D‐dimer caused by the combination of BRAF and MEK inhibitors in a patient with BRAF‐mutant melanoma.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 5, p. 707, doi. 10.1111/1346-8138.15813
- By:
- Publication type:
- Article